• Login
  • About
    • Expanded Access to New Medicines
    • COVID 19 Vaccines
    • Access to Healthcare
    • Real World Data in EAPs
    • About Us
    • Message Us!
Menu
  • Login
  • About
    • Expanded Access to New Medicines
    • COVID 19 Vaccines
    • Access to Healthcare
    • Real World Data in EAPs
    • About Us
    • Message Us!
Ax-S Pharma logo
  • VIDEOS+
    • Video Resources
    • Papers and Publications
    • Regulatory References
    • Learning Modules
    • Custom Workshop
    • Blog
  • Expanded Access Summit
  • Ax-S Thursdays
  • Faculty
Menu
  • VIDEOS+
    • Video Resources
    • Papers and Publications
    • Regulatory References
    • Learning Modules
    • Custom Workshop
    • Blog
  • Expanded Access Summit
  • Ax-S Thursdays
  • Faculty
Expanded Access 4.0 Registration Now Open! Join us for the largest annual conference on pre-market access to medicines. Now in virtual format. Register Now
  • Login
  • About
    • Expanded Access to New Medicines
    • COVID 19 Vaccines
    • Access to Healthcare
    • Real World Data in EAPs
    • About Us
    • Message Us!
Menu
  • Login
  • About
    • Expanded Access to New Medicines
    • COVID 19 Vaccines
    • Access to Healthcare
    • Real World Data in EAPs
    • About Us
    • Message Us!
Ax-S Pharma logo
  • VIDEOS+
    • Video Resources
    • Papers and Publications
    • Regulatory References
    • Learning Modules
    • Custom Workshop
    • Blog
  • Expanded Access Summit
  • Ax-S Thursdays
  • Faculty
Menu
  • VIDEOS+
    • Video Resources
    • Papers and Publications
    • Regulatory References
    • Learning Modules
    • Custom Workshop
    • Blog
  • Expanded Access Summit
  • Ax-S Thursdays
  • Faculty

Publication Category: Rights Reserved by Publisher

<a href="https://www.biocentury.com/article/240963/fda-industry-patient-groups-charting-compassionate-use-policies" target="_blank" rel="noopener noreferrer">“Scaling Compassion” <span id="title">Usdin</span> <span id="author-date">BioCentury, November 2015</span></a>

Visit Site

<a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2385762" target="_blank" rel="noopener noreferrer">“Crowdsourcing Clinical Trials” <span id="title">Darrow</span> <span id="author-date">Minnesota Law Review, January 2014 </span></a>

Visit Site

<a href="https://link.springer.com/article/10.1007/s40290-015-0091-9" target="_blank" rel="noopener noreferrer">“Global Access Programs: A Collaborative Approach for Effective Implementation and Management” <span id="title">Ainge, Aitken, Corbett, De-Keyzer</span> <span id="author-date">Pharmaceutical Magazine, March 2015</span></a>

Visit Site 

<a href="https://www.ncbi.nlm.nih.gov/books/NBK92275/" target="_blank" rel="noopener noreferrer">Envisioning a Transformed Clinical Trials Enterprise in the United States; Establishing an Agenda for 2020 Institute of Medicine<span id="title"></span> <span id="author-date">National Academies Press, November 2012</span></a>

Visit Site 

<a href="https://www.nature.com/articles/s41587-020-0686-x" target="_blank" rel="noopener noreferrer">Artificial Intelligence, Drug Repurposing, and Peer Review <span id="title">Levin, et al.</span> <span id="author-date">Nature Biotechnology, September 2020</span></a>

Visit Site 

<a href="https://pubmed.ncbi.nlm.nih.gov/19815649/" target="_blank" rel="noopener noreferrer">Results from Lepatinib (Tykerb) EAP in HER+ Breast Cancer <span id="title">Capri, et al.</span> <span id="author-date">Oxford University Press, March 2010</span></a>

Visit Site

<a href="https://academic.oup.com/jac/article/50/6/1017/809757" target="_blank" rel="noopener noreferrer">Results of Linezolid EAP in Staphylococcus Aureus Infection <span id="title">Moise, Forrest, Birmingham, Schentag</span><span id="author-date">Journal of Antimicrobial Chemotherapy, August 2002</span></a>

Visit Site

<a href="https://www.nejm.org/doi/full/10.1056/nejmhle1409465" target="_blank" rel="noopener noreferrer">“Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs” <span id="title">Darrow, Sarpatwari, Avorn, Kessleheim</span> <span id="author-date">NEJM, January 2015</span></a>

Visit Site

<a href="https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24864" target="_blank" rel="noopener noreferrer">Results of Sorafenib (Nexavar) EAP in Kidney Cancer <span id="title">Stadler, et al.</span><span id="author-date">Cancer, March 2010</span></a>

Visit Site 

<a href="https://www.nejm.org/doi/full/10.1056/NEJMp1615879" target="_blank" rel="noopener noreferrer">“Reevaluating Eligibility Criteria -Balancing Patient Protection and Participation in Oncology Trials” <span id="title">Beaver, Ison, Pazdur</span><span id="author-date">NEJM, April 2017</span></a>

Visit Site 

← older
Ax-S Pharma logo

Get In Touch

  • hello@axspharma.com
  • San Francisco, CA | Washington DC

Pages

  • Ax-S Thursdays
  • Expanded Access Summit
  • Old Faculty
Menu
  • Ax-S Thursdays
  • Expanded Access Summit
  • Old Faculty

Resources

  • Video Resources
  • Papers and Publications
  • Regulatory References
  • Learning Modules
  • Custom Workshop
  • Blog
Menu
  • Video Resources
  • Papers and Publications
  • Regulatory References
  • Learning Modules
  • Custom Workshop
  • Blog

Conatct

  • Contact Us
  • About Us
  • Privacy Policy
Menu
  • Contact Us
  • About Us
  • Privacy Policy
© 2023 Ax-S Pharma – All Rights Reserved
Facebook
Twitter
Linkedin
Instagram
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPTREJECT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT